Results 131 to 140 of about 6,317 (201)

Economic Impact of Biologics for Severe Asthma: A Case Series of 14 Patients From Northern Malaysia. [PDF]

Respirol Case Rep
Alaga A, Ismail IN.
europepmc   +1 more source

Distinct Effects of Biological Treatments on Eosinophils and Neutrophils in Chronic Rhinosinusitis With Nasal Polyp Patients. [PDF]

Clin Transl Allergy
Van Nevel S, Zhang N, Xu Z, Blauwblomme M, Vandewalle E, Holtappels G, De Ruyck N, Van Nieuwerburgh F, Vanhee S, Gevaert P, Bachert C.   +10 more
europepmc   +1 more source

Analysis of Selected Serum Cytokines to Evaluate the Early Efficacy of Benralizumab, Dupilumab, and Mepolizumab in Severe Eosinophilic Asthma Treatment. [PDF]

Int J Mol Sci
Niemiec-Górska A, Labus Ł, Mielcarska S, Glück J, Czuba Z, Cyrnek M, Branicka O, Rymarczyk B, Gawlik R.   +8 more
europepmc   +1 more source

Targeting Eosinophils in Asthmatic Inflammation: Benefits and Drawbacks. [PDF]

J Inflamm Res
Broide D.
europepmc   +1 more source

Steroid resistant, osimertinib induced hypereosinophilic syndrome (HES) treated with Benralizumab in a patient with metastatic adenocarcinoma of lung. [PDF]

Respir Med Case Rep
Al Torkmani M, Abid H, Al Kassar Y, Al Maashari R, Gaba W, Athar S, Najib M, Tufail M.   +7 more
europepmc   +1 more source

Robust evidence of the rapid efficacy of benralizumab. [PDF]

J Thorac Dis
Nagano T.
europepmc   +1 more source

Correction: Damiański et al. Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. <i>Biomedicines</i> 2025, <i>13</i>, 887. [PDF]

Biomedicines
Damiański P, Białas AJ, Kołacińska-Flont M, Elgalal A, Jarmakowska K, Kierszniewska D, Panek M, Kardas G, Kuna P, Kupczyk M.   +9 more
europepmc   +1 more source

Potential masking of new-onset or relapsed eosinophilic granulomatosis with polyangiitis during benralizumab treatment: A case series. [PDF]

J Allergy Clin Immunol Glob
Ohmura SI, Yonezawa H, Ohkubo Y.
europepmc   +1 more source

A plain language summary of the MIRACLE study: benralizumab in people in Asia with severe asthma. [PDF]

Immunotherapy
Lai K, Sun D, Dai R, Park HS, Åstrand A, Cohen D, Jison M, Shih VH, Werkström V, Yao Y, Zhang Y, Zhong N, MIRACLE Study Investigators.   +12 more
europepmc   +1 more source

Benralizumab in a Patient With Refractory Eosinophilic Endocarditis. [PDF]

J Med Cases
Schultz HM, Valdes D, Butendieck RR, Rivera CE.   +3 more
europepmc   +1 more source